Literature DB >> 26177994

Drug-induced myopathy in a patient with pulmonary tuberculosis.

Rajiv Shah1, Pradhib Venkatesan1.   

Abstract

A 26-year-old man, who had started treatment for pulmonary tuberculosis, developed polyarthralgia, generalised myalgia, weakness, and elevated uric acid and creatine kinase levels. His polyarthralgia improved on cessation of pyrazinamide, but the improvement in his myalgia and creatine kinase was delayed. Drug-induced myopathy was considered as there were no clear alternative explanations. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177994      PMCID: PMC4513556          DOI: 10.1136/bcr-2014-206906

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Drug-related myopathies of which the clinician should be aware.

Authors:  Ritu Valiyil; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

2.  A case of pyrazinamide-associated myoglobinuric renal failure.

Authors:  S Namba; T Igari; K Nishiyama; K Hashimoto; T Takemura; K Kimura
Journal:  Jpn J Med       Date:  1991 Sep-Oct

Review 3.  Drug-induced lupus: an update.

Authors:  S Vasoo
Journal:  Lupus       Date:  2006       Impact factor: 2.911

4.  Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.

Authors:  Virginie Guillet; Arnaud Chevrollier; Julien Cassereau; Franck Letournel; Naïg Gueguen; Laurence Richard; Valérie Desquiret; Christophe Verny; Vincent Procaccio; Patrizia Amati-Bonneau; Pascal Reynier; Dominique Bonneau
Journal:  Mitochondrion       Date:  2009-11-10       Impact factor: 4.160

Review 5.  Toxic and drug-induced myopathies.

Authors:  M C Dalakas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08       Impact factor: 10.154

6.  Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.

Authors:  J E Heng; C K Vorwerk; E Lessell; D Zurakowski; L A Levin; E B Dreyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

7.  Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.

Authors:  M Zierski; E Bek
Journal:  Tubercle       Date:  1980-03

Review 8.  Iatrogenic and toxic myopathies.

Authors:  Joern P Sieb; Thomas Gillessen
Journal:  Muscle Nerve       Date:  2003-02       Impact factor: 3.217

9.  Drug-induced myopathies in man.

Authors:  R J Lane; F L Mastaglia
Journal:  Lancet       Date:  1978-09-09       Impact factor: 79.321

10.  Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.

Authors:  Joo Ho Lee; Hye-Kyung Park; Jeong Heo; Tae Oh Kim; Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Mong Cho; Dae Sung Kim; Hwal Woong Kim; Chang Hun Lee
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.